Webinar
Innovations in biosimilars: what health systems professionals should anticipate for 2026
Biosimilars offer opportunities to reduce costs, optimize treatment options, and improve patient access. As the market landscape continues to grow and evolve, health system professionals must stay ahead of the curve to effectively integrate these therapies into clinical and operational workflows. This program provides critical insights into the latest innovations and trends in biosimilars, equipping participants with the knowledge to anticipate and prepare for the challenges and opportunities of 2026.
Key insights
- Emerging Biosimilars Pipeline: A look at the biosimilars expected to launch in 2026 and their potential impact on therapeutic areas such as oncology, immunology, and more.
- Regulatory and Policy Developments: Updates on evolving FDA guidelines, interchangeability designations, and reimbursement models shaping biosimilar adoption.
- Operational Integration: Best practices for incorporating biosimilars into formularies, care pathways, and inventory management systems.
Speakers:
- Tasmina Hydery, PharmD, MBA, BCGP, FAMCP, Director, FormularyDecisions®
- Cynthia Thai, PharmD, Assistant Director, FormularyDecisions®
- Tatiana Tsybulevsky, MHA, CSM, CPM, Director of Commercial Solutions, Product Deployment, and Customer Success
